Blood pressure and the therapy of advanced heart failure

Journal of the American College of Cardiology

Volumn 43, Issue 8, 2004, Pages 1430-1431

  Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; NITRATE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTERIAL PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXPERIENCE; HEART AUSCULTATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; HYPOTENSION; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT WITHDRAWAL;

EID: 1942516943     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.01.019     Document Type: Editorial

References (14)

1. Cohn J.N. Vasodilator therapy for heart failure The influence of impedance on left ventricular performance. Circulation. 48:1973;5-8.
2. Cohn J.N. Blood pressure measurement in shock Mechanism of inaccuracy in auscultatory and palpatory methods. JAMA. 199:1967;972-976.
3. Cohn J.N., Luria M.H. Studies in clinical shock and hypotension. The value of bedside hemodynamic observations. JAMA. 190:1964;891-896.
4. Franciosa J.A., Guiha N.H., Limas C.J., Rodriguera E., Cohn J.N. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet. 1:1972;650-654.
5. Cohn J.N. Blood pressure and cardiac performance. Am J Med. 55:1973;351-361.
6. Levine T.B., Francis G.S., Goldsmith S.R., Simon A., Cohn J.N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 49:1982;1659-1666.
7. Rouleau JL, Roecker EB, Tendera M, et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 2004;43:1423-9.
8. Mikulic E., Cohn J.N., Franciosa J.A. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure. Circulation. 56:1977;528-533.
9. Hall S.A., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., Eichhorn E.J. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 25:1995;1154-1161.
10. Cohn J.N., Archibald D.G., Ziesche S., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT). N Engl J Med. 314:1986;1547-1552.
11. Greenberg B., Quinones M.A., Koilpillai C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation. 91:1995;2573-2581.
12. Cohn J.N., Tognoni G., Valsartan Heart Failure Trial investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 345:2001;1667-1675.
13. Münzel T., Kurz S., Rajagopalan S., et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. J Clin Invest. 98:1996;1465-1470.
14. McDonald K.M., Francis G.S., Matthews J.H., Hunter D., Cohn J.N. Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. J Am Coll Cardiol. 21:1993;514-522.